Nocturia may be sign for future coronary heart disease
By David Liu PHD
Sunday July 8, 2012 (foodconsumer.org) -- A new study recently published in BJUI suggests that moderate nocturia may increase risk of coronary heart disease in younger men and death risk in older men.
In the study of 2447 men who were followed for an average of 17 years, moderate nocturia was defined as waking to urinate more than twice per night. Younger men were defined as being younger than 60 years old.
The study led by Deborah J. Lightner of Mayo Clinic, Rochester, MN and colleagues showed younger men with moderate nocturia were 68 percent more likely to develop coronary heart disease later in life than those without nocturia. The increase was attenuated to 36 percent after adjustment for age, body mass index, and urological medications. Researchers said the increase was not significant.
Additionally researchers found Older men with moderate nocturia was 48 percent more likely to die than those without moderate nocturia, even after adjusting for age, BMI, urological medicals and coronary heart disease.
Nevertheless, moderate nocturia was not significantly correlated with the later development of diabetes mellitus or hypertension.
It was concluded that "nocturia may be a marker for increased risk of CHD in younger men, and death in older men."
Coronary heart disease also known as coronary artery disease is a major form of heart disease. This disease can be reversed by following a plant-food based diet, according to Dr. T Colin Campbell, a Cornell University nutrition professor.
(Send your news to firstname.lastname@example.org, Foodconsumer.org is part of the Infoplus.com ™ news and information network)
- Elevated cholesterol and triglycerides may increase the risk for prostate cancer recurrence
- New Film “Second Opinion” Exposes the Truth About a 40-Year Long Cover-Up of Laetrile Cancer Treatment
- AMS Health Sciences, LLC Issues Voluntary Recall of Saba Shark Cartilage Complex, 60 Capsule Bottles
- Paleolithic diet, Mediterranean diet linked to lower colorectal cancer
- Hospira Announces Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose. Preservative-Free, Due To Particulate Matter